Post Profile






In lab research, scientists slow progression of a fatal form of muscular dystrophy

ST. LOUIS -- In a paper published in the Nature journal Scientific Reports, Saint Louis University (SLU) researchers report that a new drug reduces fibrosis (scarring) and prevents loss of muscle function in an animal model of Duchenne muscular dystrophy (DMD), providing a promising approach in designing new medications for those suffering from DMD.
read more

share

Related Posts


Protecting the pancreas: Compound fights fibrosis in animal model

Academics / General Science : Science Codex

ST. LOUIS -- Saint Louis University researchers have found that a type of compound that disrupts the process that causes fibrosis (scarring) in the lungs and liver also shows promise in preventing and treating fibrosis in yet anothe...

UMN researchers find animal model for understudied type of muscular dystrophy

Academics / General Science : Science Codex

MINNEAPOLIS/ST. PAUL (August 28, 2014) – Researchers at the University of Minnesota have developed an animal research model for facioscapulohumeral muscular dystrophy (FSHD) to be used for muscle regeneration research as well as stu...

Study shows that Wnt secretion preventing drugs may reduce renal fibrosis

Academics / General Science : Science Codex

Renal fibrosis or the scarring of kidneys, following an injury, reduces their function and can cause kidney disease to progressively worsen. In a recent study, published in Kidney International, researchers from Duke-NUS Medical Sch...

In lab research, Saint Louis University scientists limit autistic behavior

Academics / General Science : Science Codex

ST. LOUIS -- In a study published this week in ACS Chemical Neuroscience, Saint Louis University researchers report that treating mice with a compound, SR1078, reduces autistic behavior. The drug, developed by Thomas Burris, Ph.D., ...

In Lab Research, Scientists Slow Progression of a Fatal Form of Muscular Dystrophy

Health : Newswise Medical News

Saint Louis University researchers report that a new drug reduces fibrosis (scarring) and prevents loss of muscle function in an animal model of Duchenne muscular dystrophy (DMD).

Comments


Copyright © 2016 Regator, LLC